{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:50:26Z","timestamp":1790520626037,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Phospholipase A2 Receptor 1 (PLA2R1) was first identified for its ability to bind some secreted PLA2s (sPLA2s). It belongs to the C-type lectin superfamily and it binds different types of proteins. It is likely a multifunctional protein that plays a role i) in inflammation and inflammatory diseases, ii) in cellular senescence, a mechanism participating in aging and age-related diseases including cancer, and iii) in membranous nephropathy (MN), a rare autoimmune kidney disease where PLA2R1 is the major autoantigen. To help study the role of PLA2R1 in these pathophysiological conditions, we have generated a versatile NeoR-hPLA2R1 conditional transgenic mice which will allow the specific expression of human PLA2R1 (hPLA2R1) in relevant organs and cells following Cre recombinase-driven excision of the NeoR-stop cassette flanked by LoxP sites. Proof-of-concept breeding of NeoR-hPLA2R1 mice with the ubiquitous adenoviral EIIa promoter-driven Cre mouse line resulted in the expected excision of the NeoR-stop cassette and the expression of hPLA2R1 in all tested tissues. These Tg-hPLA2R1 animals breed normally, with no reproduction or apparent growth defect. These models, especially the NeoR-hPLA2R1 conditional transgenic mouse line, will facilitate the future investigation of PLA2R1 functions in relevant pathophysiological contexts, including inflammatory diseases, age-related diseases and MN.<\/jats:p>","DOI":"10.1038\/s41598-020-64863-y","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T10:02:50Z","timestamp":1589796170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Generation of a conditional transgenic mouse model expressing human Phospholipase A2 Receptor 1"],"prefix":"10.1038","volume":"10","author":[{"given":"Sara","family":"Jaber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Goehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Massemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bihl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Chabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Lambeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vindrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"64863_CR1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0021-9258(17)42060-6","volume":"269","author":"G Lambeau","year":"1994","unstructured":"Lambeau, G., Ancian, P., Barhanin, J. & Lazdunski, M. Cloning and expression of a membrane receptor for secretory phospholipases A2. J. Biol. Chem. 269, 1575\u20131578 (1994).","journal-title":"J. Biol. Chem."},{"key":"64863_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0165-6147(99)01300-0","volume":"20","author":"G Lambeau","year":"1999","unstructured":"Lambeau, G. & Lazdunski, M. Receptors for a growing family of secreted phospholipases A2. Trends Pharmacol. Sci. 20, 162\u2013170 (1999).","journal-title":"Trends Pharmacol. Sci."},{"key":"64863_CR3","doi-asserted-by":"publisher","first-page":"13146","DOI":"10.1021\/bi00040a028","volume":"34","author":"P Ancian","year":"1995","unstructured":"Ancian, P., Lambeau, G. & Lazdunski, M. Multifunctional activity of the extracellular domain of the M-type (180 kDa) membrane receptor for secretory phospholipases A2. Biochemistry 34, 13146\u201313151 (1995).","journal-title":"Biochemistry"},{"key":"64863_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.febslet.2015.02.016","volume":"589","author":"S Takahashi","year":"2015","unstructured":"Takahashi, S. et al. C-type lectin-like domain and fibronectin-like type II domain of phospholipase A(2) receptor 1 modulate binding and migratory responses to collagen. FEBS Lett 589, 829\u2013835 (2015).","journal-title":"FEBS Lett"},{"key":"64863_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.biochi.2010.03.015","volume":"92","author":"M Murakami","year":"2010","unstructured":"Murakami, M., Taketomi, Y., Girard, C., Yamamoto, K. & Lambeau, G. Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice. Biochimie 92, 561\u2013582 (2010).","journal-title":"Biochimie"},{"key":"64863_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biochi.2012.09.007","volume":"95","author":"M Murakami","year":"2013","unstructured":"Murakami, M. & Lambeau, G. Emerging roles of secreted phospholipase A(2) enzymes: an update. Biochimie 95, 43\u201350 (2013).","journal-title":"Biochimie"},{"key":"64863_CR7","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1074\/jbc.274.11.7043","volume":"274","author":"L Cupillard","year":"1999","unstructured":"Cupillard, L. et al. Both group IB and group IIA secreted phospholipases A2 are natural ligands of the mouse 180-kDa M-type receptor. J. Biol. Chem. 274, 7043\u20137051 (1999).","journal-title":"J. Biol. Chem."},{"key":"64863_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0090-6980(02)00022-9","volume":"68\u201369","author":"K Hanasaki","year":"2002","unstructured":"Hanasaki, K. & Arita, H. Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. Prostaglandins Other Lipid Mediat. 68\u201369, 71\u201382 (2002).","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"Pt A","key":"64863_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.biochi.2014.09.003","volume":"107","author":"M Murakami","year":"2014","unstructured":"Murakami, M. et al. Emerging roles of secreted phospholipase A2 enzymes: the 3rd edition. Biochimie 107(Pt A), 105\u2013113 (2014).","journal-title":"Biochimie"},{"key":"64863_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.4049\/jimmunol.1300738","volume":"191","author":"S Tamaru","year":"2013","unstructured":"Tamaru, S. et al. Deficiency of phospholipase A2 receptor exacerbates ovalbumin-induced lung inflammation. J. Immunol. 191, 1021\u20131028 (2013).","journal-title":"J. Immunol."},{"key":"64863_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1165\/rcmb.2015-0150OC","volume":"55","author":"JD Nolin","year":"2016","unstructured":"Nolin, J. D. et al. Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma. Am. J. Respir. Cell Mol. Biol. 55, 825\u2013836 (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"64863_CR12","doi-asserted-by":"publisher","first-page":"32792","DOI":"10.1074\/jbc.272.52.32792","volume":"272","author":"K Hanasaki","year":"1997","unstructured":"Hanasaki, K., Yokota, Y., Ishizaki, J., Itoh, T. & Arita, H. Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice. J. Biol. Chem. 272, 32792\u201332797 (1997).","journal-title":"J. Biol. Chem."},{"key":"64863_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/CIRCRESAHA.114.302319","volume":"114","author":"H Mishina","year":"2014","unstructured":"Mishina, H. et al. Lack of phospholipase A2 receptor increases susceptibility to cardiac rupture after myocardial infarction. Circ. Res. 114, 493\u2013504 (2014).","journal-title":"Circ. Res."},{"key":"64863_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0014-5793(95)01005-Y","volume":"373","author":"K Hanada","year":"1995","unstructured":"Hanada, K. et al. Human pancreatic phospholipase A2 stimulates the growth of human pancreatic cancer cell line. FEBS Lett 373, 85\u201387 (1995).","journal-title":"FEBS Lett"},{"key":"64863_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep06660","volume":"4","author":"Y Pan","year":"2014","unstructured":"Pan, Y. et al. sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor. Sci. Rep 4, 6660 (2014).","journal-title":"Sci. Rep"},{"key":"64863_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/eci.12292","volume":"44","author":"A Skoberne","year":"2014","unstructured":"Skoberne, A. et al. Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen. Eur. J. Clin. Invest 44, 753\u2013765 (2014).","journal-title":"Eur. J. Clin. Invest"},{"key":"64863_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/embor.2008.255","volume":"10","author":"A Augert","year":"2009","unstructured":"Augert, A. et al. The M-type receptor PLA2R regulates senescence through the p53 pathway. EMBO Rep 10, 271\u2013277 (2009).","journal-title":"EMBO Rep"},{"key":"64863_CR18","doi-asserted-by":"crossref","unstructured":"Griveau, A. et al. Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes. Aging Cell e12835 (2018).","DOI":"10.1111\/acel.12835"},{"key":"64863_CR19","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1158\/0008-5472.CAN-13-0318","volume":"73","author":"D Vindrieux","year":"2013","unstructured":"Vindrieux, D. et al. PLA2R1 mediates tumor suppression by activating JAK2. Cancer Res. 73, 6334\u20136345 (2013).","journal-title":"Cancer Res."},{"key":"64863_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-576","volume":"12","author":"M Menschikowski","year":"2012","unstructured":"Menschikowski, M. et al. Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells. BMC. Cancer 12, 576 (2012).","journal-title":"BMC. Cancer"},{"key":"64863_CR21","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.18632\/oncotarget.1681","volume":"5","author":"D Vindrieux","year":"2014","unstructured":"Vindrieux, D. et al. Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth. Oncotarget. 5, 1004\u201313 (2014).","journal-title":"Oncotarget."},{"key":"64863_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.freeradbiomed.2013.08.177","volume":"65C","author":"A Augert","year":"2013","unstructured":"Augert, A. et al. PLA2R1 kills cancer cells by inducing mitochondrial stress. Free Radic. Biol. Med. 65C, 969\u2013977 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"64863_CR23","first-page":"40","volume":"1846","author":"D Bernard","year":"2014","unstructured":"Bernard, D. & Vindrieux, D. PLA2R1: Expression and function in cancer. Biochim. Biophys. Acta 1846, 40\u201344 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"64863_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr.","year":"2009","unstructured":"Beck, L. H. Jr. et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361, 11\u201321 (2009).","journal-title":"N. Engl. J. Med."},{"key":"64863_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.kint.2016.09.048","volume":"91","author":"DC Cattran","year":"2017","unstructured":"Cattran, D. C. & Brenchley, P. E. Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int. 91, 566\u2013574 (2017).","journal-title":"Kidney Int."},{"key":"64863_CR26","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/S0140-6736(15)60731-0","volume":"385","author":"P Ronco","year":"2015","unstructured":"Ronco, P. & Debiec, H. Pathophysiological advances in membranous nephropathy: time for a shift in patient\u2019s care. Lancet 385, 1983\u20131992 (2015).","journal-title":"Lancet"},{"key":"64863_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrneph.2017.92","volume":"13","author":"P Ruggenenti","year":"2017","unstructured":"Ruggenenti, P., Fervenza, F. C. & Remuzzi, G. Treatment of membranous nephropathy: time for a paradigm shift. Nat. Rev. Nephrol 13, 563\u2013579 (2017).","journal-title":"Nat. Rev. Nephrol"},{"key":"64863_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1056\/NEJMc1500130","volume":"372","author":"M Godel","year":"2015","unstructured":"Godel, M., Grahammer, F. & Huber, T. B. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N. Engl. J. Med 372, 1073 (2015).","journal-title":"N. Engl. J. Med"},{"key":"64863_CR29","first-page":"1074","volume":"372","author":"C Meyer-Schwesinger","year":"2015","unstructured":"Meyer-Schwesinger, C., Lambeau, G. & Stahl, R. A. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N. Engl. J. Med. 372, 1074\u20131075 (2015).","journal-title":"N. Engl. J. Med."},{"key":"64863_CR30","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1172\/JCI85265","volume":"126","author":"NM Tomas","year":"2016","unstructured":"Tomas, N. M. et al. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy. J. Clin. Invest 126, 2519\u20132532 (2016).","journal-title":"J. Clin. Invest"},{"key":"64863_CR31","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1021\/bi062119b","volume":"46","author":"M Rouault","year":"2007","unstructured":"Rouault, M. et al. Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. Biochemistry 46, 1647\u20131662 (2007).","journal-title":"Biochemistry"},{"key":"64863_CR32","first-page":"135","volume":"2","author":"DB Borza","year":"2013","unstructured":"Borza, D. B., Zhang, J. J., Beck, L. H. Jr., Meyer-Schwesinger, C. & Luo, W. Mouse models of membranous nephropathy: the road less travelled by. Am. J. Clin. Exp. Immunol. 2, 135\u2013145 (2013).","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"64863_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1681\/ASN.2014050502","volume":"26","author":"M Fresquet","year":"2015","unstructured":"Fresquet, M. et al. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J. Am. Soc. Nephrol. 26, 302\u2013313 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"64863_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.biochi.2015.08.007","volume":"118","author":"B Seitz-Polski","year":"2015","unstructured":"Seitz-Polski, B. et al. Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy. Biochimie 118, 104\u2013115 (2015).","journal-title":"Biochimie"},{"key":"64863_CR35","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1073\/pnas.0610155104","volume":"104","author":"T Matsuda","year":"2007","unstructured":"Matsuda, T. & Cepko, C. L. Controlled expression of transgenes introduced by in vivo electroporation. Proc. Natl. Acad. Sci. U. S. A 104, 1027\u20131032 (2007).","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"64863_CR36","doi-asserted-by":"publisher","first-page":"E92","DOI":"10.1093\/nar\/28.21.e92","volume":"28","author":"M Holzenberger","year":"2000","unstructured":"Holzenberger, M. et al. Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene. Nucleic Acids Res 28, E92 (2000).","journal-title":"Nucleic Acids Res"},{"key":"64863_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/gene.10164","volume":"35","author":"MJ Moeller","year":"2003","unstructured":"Moeller, M. J., Sanden, S. K., Soofi, A., Wiggins, R. C. & Holzman, L. B. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis. 35, 39\u201342 (2003).","journal-title":"Genesis."},{"key":"64863_CR38","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/ndt\/gfq029","volume":"25","author":"H Yokoi","year":"2010","unstructured":"Yokoi, H. et al. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice. Nephrol. Dial. Transplant. 25, 2120\u20132124 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"64863_CR39","doi-asserted-by":"publisher","first-page":"F487","DOI":"10.1152\/ajprenal.00275.2016","volume":"311","author":"MH Foster","year":"2016","unstructured":"Foster, M. H. Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes. Am. J. Physiol Renal Physiol 311, F487\u2013F495 (2016).","journal-title":"Am. J. Physiol Renal Physiol"},{"key":"64863_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-020117-043811","volume":"15","author":"P Ronco","year":"2020","unstructured":"Ronco, P. & Debiec, H. Molecular Pathogenesis of Membranous Nephropathy. Annu. Rev. Pathol 15, 287\u2013313 (2020).","journal-title":"Annu. Rev. Pathol"},{"key":"64863_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MNH.0000000000000459","volume":"28","author":"DJ Salant","year":"2019","unstructured":"Salant, D. J. Unmet challenges in membranous nephropathy. Curr. Opin. Nephrol. Hypertens. 28, 70\u201376 (2019).","journal-title":"Curr. Opin. Nephrol. Hypertens."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64863-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64863-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64863-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:28:39Z","timestamp":1670326119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64863-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["64863"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-64863-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"26 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8190"}}